Your browser version may not work well with NCBI's Web applications. More information here...
1: Peptides. 2002 Feb;23(2):305-21.Click here to read Links

Structure and receptor binding of PYY analogs.

Keire DA, Bowers CW, Solomon TE, Reeve JR Jr.

CURE Digestive Diseases Research Center, Greater Los Angeles Veterans Health Care System, Los Angeles, CA 90073, USA. dkeire@ucla.edu

Differences in the structure of PYY and two important analogs, PYY [3-36] and [Pro34]PYY, are evaluated. Y-receptor subtype ligand binding data are used in conjunction with structural data to develop a model for receptor subtype selective agonists. For PYY it is proposed that potent binding to Y1, Y4 and Y5 receptors requires the juxtaposition of the two termini while Y2 binding only requires the C-terminal helix. Further experiments that delineate between primary and tertiary structure contributions for receptor binding and activation are required to support the hypothesis that tertiary structure is stable enough to influence the expression of PYY's bioactivity.

PMID: 11825645 [PubMed - indexed for MEDLINE]